Patent: 9,227,031
✉ Email this page to a colleague
Summary for Patent: 9,227,031
| Title: | Nasal delivery device |
| Abstract: | A drinking actuated device for delivering a substance to the nasal cavity of a subject, comprising: a container for containing the substance; a nosepiece extending from the device for placement in proximity to the nose of a subject, with the nosepiece in fluid communication with the container; a valve mechanically connectable to the container, characterized by an active configuration and an inactive configuration; and a trigger mechanism adapted to reversibly reconfigure the valve from the active configuration to the inactive configuration. The mouthpiece is fluidly connectable to by means of a tubule to a fluid reservoir containing a fluid. Drawing liquid from the reservoir into the mouth via the mouthpiece reconfigures the valve from the inactive configuration to the active configuration for a predetermined period of time in response to the pressure gradient generated by the suction applied by the subject to the tubule. |
| Inventor(s): | Shahaf; Daniel (M.P. Emek Ha-Yarden, IL), Hadash; Joseph (Lapid, IL) |
| Assignee: | SIPNOSE LTD. (Yokne\'am Ilit, IL) |
| Application Number: | 13/783,629 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,227,031
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2039-03-29 |
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-03-29 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
